Advertise
Resources
Member, Beacon International Group, Ltd.
The U.S. Supreme Court's 6-3 decision to overturn the Chevron deference will significantly impact health care regulation, shifting interpretive authority from federal agencies to the courts, Fierce Healthcare reports. Experts predict increased judicial scrutiny on actions by agencies like the Centers for Medicare & Medicaid Services, affecting provider reimbursement cuts, drug pricing regulations and the Inflation Reduction Act.